Director named for UT Health Cancer Center
Written by Rosanne Fohn
Ruben A. Mesa, M.D., professor of medicine and chair of the Division of Hematology & Medical Oncology at the Mayo Clinic in Arizona and deputy director of the Mayo Clinic Cancer Center, has been named director of the UT Health Cancer Center, effective in August.
“We are pleased to welcome Dr. Mesa to our cancer center, to UT Health and to San Antonio,” said President William L. Henrich, M.D., MACP, who announced the appointment June 13. “In addition to his superb leadership, Dr. Mesa is an international expert on myeloproliferative neoplasms (MPN) and will bring with him a sizeable patient-centered research program to San Antonio.”
Dr. Mesa has been a principal investigator or co-principal investigator of more than 70 clinical trials for patients and has led efforts in obtaining U.S. Food and Drug Administration (FDA) approval for several new cancer drugs.
“Dr. Mesa’s activities include significant roles serving as a patient advocate in cancer care helping communities, states and governments better understand and plan for the burden of this dreadful disease. He is highly engaged and demonstrates a commitment to serving the needs of patients compassionately,” Dr. Henrich added.
Dr. Mesa described San Antonio as “a warm, unique community. I look forward to working with colleagues whose commitment aligns with putting patients first and continually striving to alleviate the burden of cancer through the highest quality patient care, scientific discovery and integrity, and providing a medical education with clear distinction in new, innovative models for clinical education.
“We are aligned in our mission to end cancer,” he added. “We will continue to make life-changing breakthroughs in cancer research and care for Texans and beyond. This is an exceptional opportunity to take full advantage of the tremendous assets of the UT Health Cancer Center and our affiliation with MD Anderson Cancer Center to defeat this disease.”